Study of SYHX1901 for severe alopecia areata
Treatments studied
Part of Skin clinical trials.
This trial tests an oral medication called SYHX1901 for people with severe alopecia areata (at least 50% scalp hair loss). It aims to see if the drug can help hair regrow and is safe. It might be an option if your hair loss started less than 10 years ago and hasn't improved naturally in the last 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have alopecia areata with at least 50% scalp hair loss (SALT score ≥ 50).
- Your current hair loss started less than 10 years ago, and you have not seen natural hair regrowth in the last 6 months.
- You can understand and sign a consent form and are willing to follow the study rules.
- You agree to use effective birth control during the study and for at least 28 days after.
- You do not have other causes of hair loss (like shaving, hair implants, other scalp or medical conditions).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if upadacitinib can help young people with severe alopecia areata (a condition causing patchy hair loss) regrow their hair. It may be an option if hair loss has been present for less than 8 years and there has been no recent improvement.
This study tests whether a new drug called LY4005130 can help regrow hair in adults with severe alopecia areata (an autoimmune condition causing patchy or widespread hair loss). The trial is looking for people who have lost a significant amount of hair and haven't seen it grow back on its own for at least 6 months.
This trial tests an oral medication called NXC-736 for people with moderate to severe alopecia areata. It aims to see if the drug is safe and can help regrow hair.
This trial tests a new drug called FB102 for people with severe to very severe alopecia areata, a condition that causes at least half of scalp hair to be lost. It aims to see if the drug is safe and can help hair grow back.
This trial tests an experimental tablet for teenagers with severe alopecia areata, a condition causing patchy hair loss. The treatment may help regrow hair with clearer information about safety and effectiveness.
This trial tests a new tablet called SYHX1901 for people with moderate to severe plaque psoriasis. It aims to see if the drug can improve skin symptoms and quality of life over several months.
Hear when a new Severe Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.